Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04207060 · ClinicalTrials.gov registry record · Phase 1
Trial of Indomethacin in Chronic Pancreatitis
A Phase 1 study of Chronic Pancreatitis, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
- 2
- Study locations
NCT04207060 is a Phase 1 study of Chronic Pancreatitis that has completed, run by Mayo Clinic. The registered enrollment target is 27 participants, below the 688-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT04207060, a Phase 1 study of Chronic Pancreatitis, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
- 2
- Study locations
Study Summary
The researchers are trying to find a way to slow down the progression of chronic pancreatitis (CP) and investigate the possibility of the long term treatment of this disease.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Indomethacin
- PROCEDURE Endoscopy for Pancreatic Function Testing
Study Locations (2)
Minnesota
- Mayo Clinic - Rochester
Ohio
- Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2020-07-15 |
| Est. Completion | 2023-04-24 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04207060
The ClinicalTrials.gov registry entry for NCT04207060 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 688-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (96% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Pancreatitis appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT04207060 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Minnesota, Ohio.
Frequently Asked Questions
What is clinical trial NCT04207060 about?
NCT04207060 is a clinical study titled "Trial of Indomethacin in Chronic Pancreatitis". The researchers are trying to find a way to slow down the progression of chronic pancreatitis (CP) and investigate the possibility of the long term treatment of this disease.
What is the current status of trial NCT04207060?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2020-07-15. Estimated completion is 2023-04-24.
What conditions does trial NCT04207060 study?
This clinical trial studies the following conditions: Chronic Pancreatitis.
What interventions are being tested in trial NCT04207060?
The interventions under investigation include: Placebo (DRUG), Indomethacin (DRUG), Endoscopy for Pancreatic Function Testing (PROCEDURE).
Who is sponsoring clinical trial NCT04207060?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04207060 being conducted?
This trial has 2 study locations across Minnesota, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
RECRUITING · Phase 1
-
Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis
RECRUITING · Phase 1
-
Soy Tomato Juice to Improve Outcomes in Pancreatitis
RECRUITING · Phase 1
-
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
RECRUITING · Phase 1
-
Carbon Monoxide-Saturated Medium for Islet Isolation
COMPLETED · Phase 1
-
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.